v3.26.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-Based Compensation Expense

The stock-based compensation expense included in the Company’s consolidated statement of operations and comprehensive loss for the three months ended March 31, 2026 and 2025 is as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Research and development

 

$

3,853

 

 

$

3,411

 

General and administrative

 

 

5,180

 

 

 

4,443

 

 

$

9,033

 

 

$

7,854

 

Summary of Stock Option Activity under 2019 Plan and 2021 Plan

The following table summarizes stock option activity under the 2019 Plan, 2021 Plan and assumed options in the AnHeart acquisition for the three months ended March 31, 2026.

 

 

 

Shares

 

Outstanding at December 31, 2025

 

 

73,963,104

 

Granted

 

 

12,749,934

 

Exercised

 

 

(1,177,041

)

Forfeited

 

 

(441,100

)

Outstanding at March 31, 2026

 

 

85,094,897

 

Exercisable at March 31, 2026

 

 

40,099,370

 

Summary of Restricted Stock Units Activity

The following table summarizes the activity for the restricted stock units for the three months ended March 31, 2026.

 

 

Restricted Stock

 

 

 

Units

 

Non-vested at December 31, 2025

 

 

104,027

 

Granted

 

 

3,420,803

 

Vested

 

 

(12,615

)

Forfeited or canceled

 

 

(33,840

)

Non-vested at March 31, 2026

 

 

3,478,375